173.15

1.85% 3.15

Jazz Pharmaceuticals Plc (JAZZ)

Overview News Price History Option Chain Financials Discussions Forecast

Jazz Pharmaceuticals Plc stock is traded at $173.15, with a volume of 821.85K. It is up +1.85% in the last 24 hours and up +3.86% over the past month. Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Previous Close:

$170.00

Open:

$169.5

24h Volume:

821.85K

Relative Volume:

0.82

Market Cap:

$10.52B

Revenue:

$4.09B

Net Income/Loss:

$-404.84M

P/E Ratio:

-25.66

EPS:

-6.7469

Net Cash Flow:

$1.24B

1W Performance:

+1.57%

1M Performance:

+3.86%

6M Performance:

+57.52%

1Y Performance:

+39.91%

1-Day Range:

$169.26

$174.11

1-Week Range:

$169.26

$174.11

52-Week Range:

$95.49

$182.99

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name

Jazz Pharmaceuticals Plc

Sector

Healthcare (1131)

Industry

Biotechnology (631)

Phone

353-1-634-7800

Address

FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN

Employee

2,800

Twitter

@jazzpharma

Next Earnings Date

2024-11-06

Latest SEC Filings

JAZZ's Discussions on Twitter

Compare JAZZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JAZZ Jazz Pharmaceuticals Plc	173.15	10.33B	4.09B	-404.84M	1.24B	-6.7469
VRTX Vertex Pharmaceuticals Inc	452.13	115.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.31	81.12B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.17	52.54B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	839.99	51.78B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.12	37.12B	447.02M	-1.18B	-906.14M	-6.1812

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-24-25	Downgrade	UBS	Buy → Neutral
Jul-15-25	Initiated	Deutsche Bank	Buy
Mar-07-25	Upgrade	UBS	Neutral → Buy
Feb-26-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-13-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Dec-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-05-24	Initiated	Goldman	Buy
Jan-03-24	Initiated	Robert W. Baird	Outperform
Nov-27-23	Downgrade	UBS	Buy → Neutral
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight
Dec-09-22	Upgrade	Goldman	Neutral → Buy
Jun-14-22	Initiated	UBS	Buy
Apr-06-22	Downgrade	Goldman	Buy → Neutral
Nov-19-21	Resumed	Goldman	Buy
Oct-07-21	Resumed	Jefferies	Buy
Oct-05-21	Initiated	Citigroup	Buy
Sep-23-21	Initiated	Needham	Buy
May-19-21	Resumed	JP Morgan	Overweight
Apr-07-21	Resumed	RBC Capital Mkts	Outperform
Feb-05-21	Reiterated	H.C. Wainwright	Buy
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy
Nov-03-20	Reiterated	H.C. Wainwright	Buy
Oct-09-20	Reiterated	H.C. Wainwright	Buy
Sep-14-20	Downgrade	Goldman	Neutral → Sell
Sep-14-20	Resumed	JP Morgan	Overweight
Aug-06-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jul-28-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jul-23-20	Upgrade	H.C. Wainwright	Neutral → Buy
Apr-06-20	Initiated	Jefferies	Buy
Mar-12-20	Upgrade	Bernstein	Mkt Perform → Outperform
Jan-08-20	Initiated	Goldman	Neutral
Aug-21-19	Downgrade	Piper Jaffray	Overweight → Neutral
Jun-11-19	Initiated	Barclays	Overweight
Mar-20-19	Initiated	SunTrust	Buy
Dec-14-18	Initiated	Wolfe Research	Peer Perform
Nov-08-18	Reiterated	B. Riley FBR	Buy
Aug-08-18	Reiterated	Stifel	Buy
Jul-11-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-23-18	Reiterated	H.C. Wainwright	Neutral
Mar-19-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Jazz Pharmaceuticals Plc Stock (JAZZ) Latest News

Jan 02, 2026

Volume Summary: Will Jazz Pharmaceuticals plc stock deliver long term returnsDividend Hike & Consistent Income Trade Recommendations - moha.gov.vn

Jan 02, 2026

The Truth About Jazz Pharmaceuticals: Is Wall Street Sleeping On This Quiet Game-Changer? - AD HOC NEWS

Jan 02, 2026

Jan 01, 2026

How Jazz Pharmaceuticals Plc (JAZZ) Affects Rotational Strategy Timing - Stock Traders Daily

Jan 01, 2026

Dec 28, 2025

Corient Private Wealth LLC Cuts Stock Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Dec 28, 2025

Reflecting On Pharmaceuticals Stocks' Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) - Finviz

Dec 28, 2025

Dec 26, 2025

Pacer Advisors Inc. Sells 194,639 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Dec 26, 2025

Dec 22, 2025

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After a Strong Year-to-Date Share Price Rally - simplywall.st

Dec 22, 2025

Dec 21, 2025

Jazz Pharmaceuticals (FRA:J7Z) EV-to-OCF : 9.16 (As of Dec. 21, 2025) - GuruFocus

Dec 21, 2025

Update Report: What sentiment indicators say about Jazz Pharmaceuticals plc stockIPO Watch & Risk Controlled Daily Trade Plans - moha.gov.vn

Dec 21, 2025

JAZZ SEC FilingsJazz Pharmaceuticals Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 21, 2025

211,185 Shares in Jazz Pharmaceuticals PLC $JAZZ Acquired by Wedge Capital Management L L P NC - MarketBeat

Dec 21, 2025

Published on: 2025-12-21 12:21:40 - Улправда

Dec 21, 2025

Dec 20, 2025

Volume Summary: Is Jazz Pharmaceuticals plc stock positioned well for digital economy2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - ulpravda.ru

Dec 20, 2025

Perpetual Ltd Reduces Stock Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Dec 20, 2025

Dec 19, 2025

Is Jazz Pharmaceuticals plc stock positioned well for digital economy2025 Trading Volume Trends & Stock Portfolio Risk Management - ulpravda.ru

Dec 19, 2025

Jazz Pharmaceuticals (MEX:JAZZ) EV-to-OCF : 8.83 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Jazz Pharmaceuticals (MIL:1JAZZ) EV-to-FCF : 10.20 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Jazz Pharmaceuticals (MIL:1JAZZ) EV-to-OCF : 9.11 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

What sentiment indicators say about Jazz Pharmaceuticals plc stock2025 Price Targets & Real-Time Stock Price Movement Reports - DonanımHaber

Dec 19, 2025

Resistance Check: Why Jazz Pharmaceuticals plc stock remains resilientChart Signals & Weekly Chart Analysis and Trade Guides - DonanımHaber

Dec 19, 2025

Is Jazz Pharmaceuticals plc stock cheap compared to fundamentalsBear Alert & Expert Approved Trade Ideas - Улправда

Dec 19, 2025

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 19, 2025

Is It Too Late To Consider Jazz Pharmaceuticals After Its Strong 2024 Share Price Rally? - Yahoo Finance

Dec 19, 2025

Dec 18, 2025